Global /Indonesia /Healthcare /Medical Care Facilities /DGNS

PT Diagnos Laboratorium Utama Tbk

DGNS

• IDX: DGNS • Delayed

266.00IDR -4.3%

0.0147 USD

As of 7 June 2026, PT Diagnos Laboratorium Utama Tbk has a market cap of $19.3M USD, ranking #37334 globally and #675 in Indonesia. It ranks #3350 in the Healthcare sector, and #404 in the Medical Care Facilities industry.

Global Rank

37334

Country Rank

675

Sector Rank

3350

Industry Rank

404

Key Stats

Market Cap

$19.3MUSD

347.5B IDR

Enterprise Value

$22.87MUSD

414.71B IDR

Revenue (TTM)

$9.25MUSD

166.62B IDR

EBITDA (TTM)

$822.36KUSD

14.91B IDR

Net Income (TTM)

$163.1KUSD

2.94B IDR

EBITDA Margin

8.9%

Profit Margin

1.8%

PE Ratio

118.3

PS Ratio

2.1

PB Ratio

1.7

EV/EBITDA

24.2

Company Profile

Country (HQ)

Indonesia

Sector

Healthcare

Industry

Medical Care Facilities

CEO

Fergus Richard open_in_new

Employees

111

Founded

2007

Website

diagnos.co.id open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-4.3%	-1.4%	-6.7%	-6.7%	87%	51%	64%	17%	-52%

News

Markets

Exchange	Ticker	Price	Quotes
Indonesia Stock Exchange (IDX) MIC: XIDX PRIMARY	DGNS PT Diagnos Laboratorium Utama Tbk Ordinary Shares ISIN: ID1000158702 Shares Out.: Shares Outstanding: 1.28B¹ Shares Float: 255.93M² TV: TradingView: IDX: DGNS SA: Stock Analysis: IDX: DGNS YF: Yahoo Finance: DGNS.JK GF: Google Finance: IDX: DGNS BA: Barron's: DGNS MS: Morningstar: XIDX: DGNS	266.00 IDR	TV: TradingView: IDX: DGNS SA: Stock Analysis: IDX: DGNS YF: Yahoo Finance: DGNS.JK GF: Google Finance: IDX: DGNS BA: Barron's: DGNS MS: Morningstar: XIDX: DGNS

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About PT Diagnos Laboratorium Utama Tbk

PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers laboratory tests comprising hemostasis, hepatitis, autoimmune and rheumatology, tumor markers, toxicology, lipid, allergies, TORCH, diabetes, electrolytes-blood gases, respiratory tract infection, pathology anatomy, neonatal screening, hematology, body fluids, feces, specific proteins, DNAnswer genomics, kidney function, liver function, immunology, osteoporosis, thyroid, pharmacogenomic, heart, reproduction and fertility, microbiology, drug monitoring, lungs, gastrointestinal, nutrition and heavy metals, anemia and other bacteria; genomics, homecare services; and inspection panel tests. It also provides doctor consultation; clinic services; corporate health services. PT Diagnos Laboratorium Utama Tbk was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia.

Similar Companies

Industry: Medical Care Facilities (Indonesia)

Name	Market Cap (USD) diff.	PE	Country
PT Sejahteraraya Anugrahjaya Tbk IDX: SRAJ	$10.11B 182.11T IDR 52K%	-	Indonesia
PT Siloam International Hospitals Tbk IDX: SILO	$1.82B 32.73T IDR 9K%	29.4	Indonesia
PT Mitra Keluarga Karyasehat Tbk IDX: MIKA	$1.5B 26.98T IDR 8K%	19.8	Indonesia
PT Medikaloka Hermina Tbk IDX: HEAL	$998.34M 17.98T IDR 5K%	41.2	Indonesia
PT Metro Healthcare Indonesia Tbk IDX: CARE	$753.33M 13.57T IDR 4K%	2739.1	Indonesia
PT Famon Awal Bros Sedaya Tbk IDX: PRAY	$577.5M 10.4T IDR 3K%	49.2	Indonesia

Industry: Medical Care Facilities (Global)

Name	Market Cap (USD) diff.	PE	Country
International Holding Company PJSC ADX: IHC	$232.18B 852.82B AED 1M%	44.1	United Arab Emirates
HCA Healthcare, Inc. NYSE: HCA	$96.73B 501K%	14.9	United States
Fresenius SE & Co. KGaA XETRA: FRE	$26.68B 22.97B EUR 138K%	15.0	Germany
Koninklijke Philips N.V. AMS: PHIA	$25.58B 22.02B EUR 132K%	24.9	Netherlands
Dr. Sulaiman Al Habib Medical Services Group Co. TADAWUL: 4013	$22.48B 84.42B SAR 116K%	35.2	Saudi Arabia
Labcorp Holdings Inc. NYSE: LH	$21.13B 109K%	24.6	United States

chevron_leftBack